Veradermics, Inc Earnings Per Share (Basic)
Veradermics, Inc (MANE) reported Earnings Per Share (Basic) of -$0.58 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-11
- Veradermics, Inc earnings per share, basic for the quarter ending 2026-06-30 was -$0.58.
- Veradermics, Inc earnings per share, basic for the quarter ending 2026-03-31 was -$1.32.
- Veradermics, Inc earnings per share, basic for the quarter ending 2025-06-30 was -$24.19.
- Veradermics, Inc earnings per share, basic for the quarter ending 2025-03-31 was -$19.79.
- Veradermics, Inc earnings per share, basic for fiscal 2025 was -$111.91.
- Veradermics, Inc earnings per share, basic for fiscal 2024 was -$37.05.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|
| 2026-06-30 | -$0.58 10-Q · filed 2026-08-11 | -$1.69 10-Q · filed 2026-08-11 | |
| 2026-03-31 | -$1.32 10-Q · filed 2026-05-12 | ||
| 2025-12-31 | -$111.91 10-K · filed 2026-03-30 | ||
| 2025-06-30 | -$24.19 10-Q · filed 2026-08-11 | -$44.00 10-Q · filed 2026-08-11 | |
| 2025-03-31 | -$19.79 10-Q · filed 2026-05-12 | ||
| 2024-12-31 | -$37.05 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |